Anthony Squeglia
2009
In 2009, Anthony Squeglia earned a total compensation of $157.7K as Chief Financial Officer at Galectin Therapeutics.
Compensation breakdown
| Option Awards | $50,517 |
|---|---|
| Salary | $86,500 |
| Other | $20,688 |
| Total | $157,705 |
Squeglia received $86.5K in salary, accounting for 55% of the total pay in 2009.
Squeglia also received $50.5K in option awards and $20.7K in other compensation.
Rankings
In 2009, Anthony Squeglia's compensation ranked 9,512th out of 9,885 executives tracked by ExecPay. In other words, Squeglia earned more than 3.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,512 out of 9,885 | 4th |
Division Manufacturing | 3,558 out of 3,690 | 4th |
Major group Chemicals And Allied Products | 827 out of 866 | 5th |
Industry group Drugs | 610 out of 638 | 4th |
Industry Pharmaceutical Preparations | 428 out of 446 | 4th |
Source: SEC filing on April 11, 2011.
Squeglia's colleagues
We found five more compensation records of executives who worked with Anthony Squeglia at Galectin Therapeutics in 2009.
2009
Theodore Zucconi
Galectin Therapeutics
Chief Executive Officer
2009
Eliezer Zomer
Galectin Therapeutics
Executive Vice President of Manufacturing and Product Development
2009
David Platt
Galectin Therapeutics
Chief Executive Officer
2009
Anatole Klyosov
Galectin Therapeutics
Chief Scientist
2009
Maureen Foley
Galectin Therapeutics